BR100 Increased By (1.02%)
BR30 Increased By (1.71%)
KSE100 Increased By (0.58%)
KSE30 Increased By (0.65%)
BECO 6.03 Increased By ▲ 0.26 (4.51%)
BML 52.61 Decreased By ▼ -0.39 (-0.74%)
BOP 34.23 Increased By ▲ 0.24 (0.71%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.24 Increased By ▲ 0.17 (3.35%)
FFL 18.03 Increased By ▲ 0.08 (0.45%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.07 Increased By ▲ 0.05 (0.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 87.90 Increased By ▲ 1.39 (1.61%)
NBP 186.60 Increased By ▲ 1.44 (0.78%)
PACE 10.75 Increased By ▲ 0.17 (1.61%)
PAEL 39.95 Increased By ▲ 0.53 (1.34%)
PIAHCLA 26.19 Decreased By ▼ -0.03 (-0.11%)
PIBTL 17.32 Increased By ▲ 0.65 (3.9%)
PPL 233.49 Increased By ▲ 5.31 (2.33%)
PRL 34.98 Increased By ▲ 0.30 (0.87%)
PTC 67.71 Increased By ▲ 2.38 (3.64%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 60.85 Increased By ▲ 2.35 (4.02%)
TPLP 8.78 Increased By ▲ 0.56 (6.81%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
World

UK doctors call for shorter gap between Pfizer vaccine doses

Britain is prioritising giving first doses of COVID-19 vaccine, allowing up to 12 weeks before a second dose, to give the maximum number of people some initial protection. * It therefore urged the CMO to "urgently review the UK's current position of second doses after 12 weeks".
Published January 23, 2021 Updated January 23, 2021 06:27pm
By

LONDON: A group of British doctors have written to England's chief medical officer to tell him to cut the gap between doses of the Pfizer and BioNTech vaccine to six weeks from up to 12.

Britain is prioritising giving first doses of COVID-19 vaccine, allowing up to 12 weeks before a second dose, to give the maximum number of people some initial protection.

But Pfizer and BioNTech have warned they have no evidence their vaccine would continue to be protective if the second dose is given more than 21 days after the first.

The British Medical Association (BMA) said in a statement emailed on Saturday that it has written to the Chief Medical Officer (CMO) for England Chris Whitty.

The BMA said it supports giving a second dose up to 42 days after the first dose, but that a longer gap is not in line with World Health Organization guidance.

It therefore urged the CMO to "urgently review the UK's current position of second doses after 12 weeks".

"The UK's strategy has become increasingly isolated from many other countries," the BMA said.

"BMA members are also concerned that, given the unpredictability of supplies, there may not be any guarantees that second doses of the Pfizer vaccine will be available in 12 weeks' time."

Whitty told a media conference on Friday that the longer gap between doses was a "public health decision" aimed at vaccinating many more people and based on a belief that the great majority of protection comes from the first jab.

Britain is using two vaccines, one from Pfizer and the other from AstraZeneca.

AstraZeneca has supported the gap between its jabs, saying data showed an 8-12 week gap was a "sweet spot" for efficacy.

The Department of Health and Social Care said in an emailed statement that its priority was to protect as many people as possible as quickly as possible.

"The decision...to change vaccine dosage intervals followed a thorough review of the data and was in line with the recommendations of the UK's four chief medical officers," a DHSC spokeswoman said.

Some 5.38 million people have been given a first dose of vaccine in the UK, government data showed.

Comments

Comments are closed for this article.